Evaluation of the obstetrical risks of the antiphospholipid syndrome and therapeutic management.
Edelman
P
P
Department of Gynecology-Obstetrics, Bichat Hospital, Paris, France.
Rouquette
A M
AM
D017152:Antibodies, Antiphospholipid / Q000502:physiology; D016736:Antiphospholipid Syndrome / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D001241:Aspirin / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007049:Iatrogenic Disease; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000503:physiopathology / Q000628:therapy*; D012307:Risk Factors; D013927:Thrombosis / Q000209:etiology
D017152:Antibodies, Antiphospholipid; D005938:Glucocorticoids; D006493:Heparin; D001241:Aspirin